OncoSec Presents Significant Advancements in Electroporation Technology for Immunotherapy Jun 28, 2016
OncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference Jun 16, 2016
OncoSec Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy Jun 6, 2016
OncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research (AACR) Annual Meeting 2016 Apr 19, 2016
OncoSec and Heat Biologics Present Data at the American Conference for Cancer Research (AACR) Annual Meeting Apr 18, 2016
